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ABSTRACT 
Parkinson’s disease is present approximately in 10 million individuals all over the world, being 
one of the most common neurodegenerative diseases, and statistics denote that its prevalence 
will raise in the coming years. Deep brain stimulation is an effective surgical treatment for patients 
who do not improve with drug treatment and who present many motor symptoms. Deep brain 
stimulation constitutes the implantation of electrodes in specific brain structures, nevertheless, 
this study has focused on the subthalamic nucleus, being the main target region for Parkinson’s 
disease. In order to have satisfactory post-surgical results, where the patient has a considerable 
reduction in motor symptoms, it is essential to present a correct lead placement accuracy, which 
corresponds with what has been planned before surgery by terms of using the neuronavigator. 
The principal objective of this study is to validate the accuracy of the actual technique used in the 
Hospital Clínic of Barcelona, which is guided exclusively by image, as well as to establish a 
possible relationship between the patient's clinic, following the UPDRS scale type III, once it has 
undergone surgery and the accuracy of the electrodes, to verify that it essential to achieve its 
maximum effectiveness. Thus, objective arguments of the image-guided and image-verified 
technique can also be given as well as providing assertion of completing the procedure with the 
patient completely anaesthetised, since currently in Catalonia most centres do so with the patient 
awake and with microelectrode recording. 
A study has been performed on 74 patients operated on from 2015 to 2020 following the same 
methodology, where the AC-PC coordinates were acquired using Medtronic's StealthStation S8 
navigator and the errors and statistical analysis were computed with MATLAB.  
The average targeting accuracy found in the right hemisphere has been 1.923 mm ± 1.107 and in 
the left hemisphere of 2.364 mm ± 1.065, alongside the calculation of a Student t-test with a p-
value of 1.384·10-4. Furthermore, the majority of clinical results were very favourable, thus 
concluding that the protocol used in the Hospital Clínic is correct and alleviates the patient's 
anxiety. 
KEYWORDS 
Parkinson’s Disease · Deep brain stimulation · Accuracy · Targeting Accuracy · AC-PC 
coordinates · Neurosurgery · Motor symptomatology · Lead placement · Image-guided image-
verified 
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Parkinson’s disease (PD) is one of the most common neurodegenerative conditions affecting 
approximately 10 million individuals all over the world. Its cause it is still unknown, although it is 
believed that elements such as genetics and environmental factors could lead to the 
degeneration of neurons in specific brain regions which could arise the disorder. PD affects 
primarily elder people and, as life expectancy has increased significantly, statistics denote that in 
coming years PD’s prevalence will raise. [1] [2] 
PD combines many direct and indirect costs, including treatment, social assistance, psychology 
aid, among others. In Spain, the average annual expenditure may exceed 17.000€ per patient, 
whilst for the Ministry it reaches up to 2.5 million euros per year. As the disease severity 
progresses, an increase in costs is seen in tests, early retirements, hospitalisation, within others. 
In Spain, the 10% of PD patients present advanced Parkinson. [3] 
The number of people affected by PD will be doubled in 20 years and will triple by 2050, stated by 
“Sociedad Española de Neurología” (SEN). [4] Moreover, the number of patients suffering from 
severe illness and presenting motor symptomatology which does not respond to drug treatment of 
levodopa will also risen.  
Surgery is an effective treatment option for those patients whose medical treatment for tremor 
has been exhausted or whose symptoms of dyskinesia are profound. Deep brain stimulation 
(DBS) was first approved in 1997 as a therapy for PD’s tremor, and in 2002 for advanced 
Parkinson’s symptoms. Recently, in 2016, it was authorised for earlier stages of PD with motor 
symptoms not controlled by drug treatment. DBS comprises the insertion of electrodes in specific 
regions of the brain and an impulse generator battery is also implanted. It is one of the most 
important therapeutic advancements, although it is not suitable for all patients. [5] This study has 
focused on the subthalamic nucleus (STN), specifically the Bilateral Subthalamic Deep Brain 
Stimulation (STN-DBS) intervention by terms of acquiring the anterior commissure - posterior 
commissure (AC-PC) coordinates. 
Lead placement accuracy is one of the most significant concepts to take into account when 
accomplishing a DBS procedure, as the target regions are situated deep inside the brain. The 
main motivation of this project is to accomplish a precision analysis in order to establish a 
possible clinical correlation with deviations. 
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1.2. OBJECTIVES 
The main objectives proposed for this project are the following: 
• Validate the accuracy of the implantation technique guided exclusively by image, which is 
the current methodology used in the Hospital Clínic for these interventions. 
• Establish a possible relationship between Parkinson’s disease symptomatology before and 
after being submitted to DBS surgery. 
• Provide objective arguments for or against performing the surgery with the fully 
anaesthetised patient, alongside the image-guided and image-verified technique. 
1.3. METHODOLOGY 
The methodology of the project has been 
described in the workflow shown in Figure 1, 
and it is divided into two distinct groups.  
The first one is focused on the imaging 
analysis, where the neuroimages, computed 
tomography (CT) and magnetic resonance 
imaging (MRI), of patients submitted to 
stereotactic surgery due to PD condition are 
assembled after a process of anonymization 
and codification to maintain patient privacy. 
Subsequently, a pre-processing is computed 
by terms of a coregistration of the post-
implantation CT scan with the planning 
imaged fusion.  
The second group involves the assessment procedure, particularly the accuracy appraisal, and 
finally a statistical analysis in conjunction with a clinical analysis are performed. 
The project is divided into 11 sections. Firstly, an introduction concerning the specific field is 
detailed, followed by the general theoretic background of Parkinson’s disease as well as deep 
brain stimulation and error propagation. On section 3, a market analysis is precised and the 
different regulation followed during the project are shown in section 4. To mention all the 
programs available and used, the conception and detail engineering are fundamental. 
Additionally, detail engineering provides the project results and its analysis. Future research , as 
well as a general discussion, concerning DBS in PD is discussed in section 7. For the validation 
of the project, a technical and economic viability, as well as a particular project schedule are 
specified in section 8, 9 and 10. 
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1.4. SCOPE AND LIMITATIONS 
Different limitations are present in all the study, as it is a bachelor’s thesis and there is a set time 
to deliver the project and its final results. This project has been accomplished from September 
2020 to June 2021, and it is important to emphasise that the data used during this work are 
included in a time between 2015 to 2020 since only those patients who have undergone the 
intervention through image-guided surgery have been encompassed. Thus, the number of 
patients is a limitation as the population of cases studied is less than 100. Also, not all patients 
who met this requirement presented all the images necessary to perform the data acquisition or 
the target was a different structure other than STN and have been rejected. Approximately 25 
patients have been discarded for reasons similar to those mentioned above.  
Furthermore, the study has consisted on the validation of the current technique, but a more 
complete study with an improvement of the approach and with the implementation of a real-time 
algorithm that detects the error during surgery could have been a great advance, however, due to 
time limitation it has not been possible to term. 
The scope of this project included the following steps, always regarding and taking into account 
all the limitations disclosed earlier: 
• Literature review and bibliographic research of current DBS techniques and future 
challenges. 
• Analysis of different softwares such as Lead DBS and MATLAB to accomplish the 
assessment. 
• Patient’s data anonymization and co-registration of the preoperative MR image and the 
postoperative CT scan. 
• Data acquirement of AC-PC coordinates of the STN target point for both cerebral 
hemispheres. 
• Vector error assessment using MATLAB iterative loops. 
• Statistical analysis including mean, standard deviation (SD) and a Student t-test 
performance. 
• Discussion of the results and clinical relationship between them and the patient’s 
symptomatology. 
1.5. LOCATION OF THE PROJECT 
The project data acquisition, including images, has been accomplished at the Neurosurgery room 
at the Fifth Floor, pavilion 6 of the Hospital Clínic of Barcelona. Furthermore, the coregistration 
and coordinates acquirements has been carried out in the Navigation Room, on the 8th scale of 
the 4th floor of the Hospital Clínic, which is the Neurosurgery department. 
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2. BACKGROUND 
Before the analysis is realised and disputed, it is relevant to introduce general concepts which will 
be fundamental in order to understand the project. Additionally, the state-of-the-art technology in 
stereotactic surgery is analysed. 
2.1. GENERAL CONCEPTS 
General concepts such as a definition of Parkinson’s Disease, Deep Brain Stimulation, including 
precision and accuracy as neuronavigation must be clarified. 
 2.1.1. PARKINSON’S DISEASE 
Parkinson’s Disease is present on a 1% of adults older than 60 years. PD is a neurodegenerative 
condition which affects nerve cells controlling movement, presenting a progressive worsening 
pattern. PD is mainly characterised by three cardinal features: tremors, muscular rigidity and 
bradykinesia (slowness of movement). Postural instability could also be an indication, somehow, 
many times it is presented as a non-specific one. PD has an effect on motor and on non-motor 
features, these last ones being anxiety, depression, autonomic dysfunction, sensory symptoms, 
within much others. [6] 
PD is caused by the loss of dopamine-producing neurons in the substantia nigra, specifically the 
decreased of striatal 6-[F]-fluoro-L-dopa (F-DOPA). Dopamine is the neurotransmitter involved in 
motor skills, affecting the region of the brain regulating movement and balance. Nonetheless, 
dopamine is the prevailing neurotransmitter producing the motor symptoms, but other 
neurotransmitters are also implicated, causing non-motor symptomatology. [7] The primary 
indications of PD are a significant loss of dopamine as well as the presence of Lewy bodies, 
which are globs of the alpha-synuclein protein. [8] 
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Figure 2 shows how a Parkinson’s affected neuron does not present as much dopamine as a 
normal neuron, leading to movement disorders. There is also the presence of Lewy bodies on the 
neuron affected by PD. 
PD diagnosis is generally clinical, but it is difficult to diagnose as no specific test exists and 
symptoms could be common with other illnesses. Imaging could also be important to examine the 
anatomy and functioning of the patient’s brain and other structures from the nervous system. 
Techniques used vary depending on the need, but these include: 
• Magnetic Resonance Imaging (MRI): Helpful in the detection of vascular Parkinsonism 
• Computerised Tomography (CT): Based on X-Rays being passed through the brain in 
order to compute cross-section pictures of the brain. 
• Positron Emission Tomography (PET): Mainly used in research as it is expensive and not 
always available. Quantifies the functional dopaminergic terminals in the striatum. 
• DaTSCANTM-SPECT: Identifies the loss of dopamine-producing neurons. 
Moreover, newly diagnose techniques are being researched such as blood or skin tests. [9] 
There is no current therapy for PD, but some approaches such as medication or surgical 
interventions are able to slow down the symptomatology progression. Medication can be used as 
symptomatic treatment of motor and non-motor symptoms or as neuroprotection to slow down the 
disease progression. 
Surgical options to relieve symptomatology of Parkinson’s can be considered in those patient’s 
whose medication is not able to show the desired results. Surgery is conditioned to improve only 
the motor symptoms such as tremors, which are initially treated with levodopa.  
Years ago, surgery involved the demolish of specific structures of the brain implicated with motor 
symptoms including the globus pallidus, the thalamus or the subthalamus. These procedures 
involve a high probability of death, within other significant risks. Currently, deep brain 
stimulation (DBS) is the most common surgery for alleviating PD symptoms. [10] 
The Unified Parkinson's Disease Rating Scale (UPDRS) is a scale developed in order to follow a 
longitudinal course of PD providing a comprehensive and efficient mean to monitor the 
advancement of the condition. The four sub-components regarding the UPDRS are Part I 
(mentation and behaviour), Part II (evaluation of daily-life activities), Part III (motor evaluation) 
and Part IV (therapy complications). This study is focused on Part III of the UPDRS. [11] 
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 2.1.2. DEEP BRAIN STIMULATION 
Functional neurosurgery is a minimally invasive surgery based on medical images which focuses 
on functional localisations of the brain with the aim of treating different movement-related 
disorders, pain and epilepsy. Stereotactic neurosurgery assigns three cartesian coordinates (x, y 
and z) to each point of the encephal which are correlated to the preoperative planning image, 
mostly MRI, and the actual space of the patient’s brain at the operating room. It is considerably 
important to define the coordinates of the stereotactic target as also the trajectory it will follow. 
Reasons are that the encephal is highly vascularised and also, the surgeon must be able to 
introduce surgical instruments accurately avoiding dangerous structures. [12] 
Deep brain stimulation consists of a procedure where a device is implanted to the patient with the 
aim to deliver programmed electrical pulses and modulate the activity of target neurons which are 
located deep in the brain, to decrease motor symptoms. This electric current changes the 
extracellular potential of cells and fibres located nearby the electrode. The main DBS lead target 
in PD is the STN, but some other targets could include the globus pallidus internus (GPi) and the 
ventral intermediate nucleus (VIM). This lead is connected to a subcutaneous implantable pulse 
generator (IPG) located under the skin of the anterior chest wall, containing battery and 
stimulation hardware. The pulse generator is connected to a connecting wire which is tunnelled 
from the chest to the skull, where the lead is. [13] [14] Figure 3 displays how the electrode and 
the generator are placed, and how stimulation occurs in the GPi or STN shown in a sagittal cut. 
Once the implantation is fulfilled, a clinician configures the IPG parameters in order to optimise 
therapy and obtain better results treating the symptomatology. Normally stimulation is based on a 
high-frequency (60-185Hz), continuous and biphasic pulse train presenting amplitudes from 0 to 
6
Figure 3. Implantable DBS: Electrode, lead and pulse generator [13]
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10 V and pulse widths between 60 and 450 µs. Electrode implantation can be lateral or bilateral 
and stimulation is applied along the DBS lead. [14] 
DBS is indicated for those patients suffering Parkinson’s for four years or more and who do not 
always present a response to their medication, or those patients with dyskinesia. The reason is 
that DBS helps to decrease motor symptomatology; mainly the three cardinal features. This 
surgical intervention is not indicated for people suffering from dementia as DBS could worsen 
cognition or memory. [15] 
Precision and accuracy are fundamental concepts in order to proceed to a DBS implantation. 
Different strategies, both anatomical and functional, must be used to confirm the correct 
placement of the electrodes. Intraoperative imaging and computer software support such as 
neuronavigation allows surgeons to know where the electrodes are implanted. Neuronavigation 
provides an interactive correspondence between imaging studies and the surgical field thanks to 
the co-registration of virtual images with the material volume of the patient. Co-registration is 
mainly achieved by establishing common points known as fiducials which must be visible in both 
the images and the patient, or sometimes by the registration on a stereotactic frame which is 
mounted on the patient’s head. A functional strategy would be to keep the patient awake during 
surgery. 
 2.1.3. PRECISION AND ACCURACY AND PROPAGATION OF UNCERTAINTY 
Precision and Accuracy 
Accuracy is the proximity between the result of the measure and the real value, whilst precision is 
the spread of the measures, the closeness of measurements within each other. Accuracy is a 
description of systematic errors whereas precision is representation of random errors.  
Figure 4 displays the main differences between the two static characteristics: accuracy and 










Figure 4. Accuracy vs Precision [16]
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Propagation of uncertainty 
Error transmission in statistics is the effect of distinct random errors which propagate through 
each other. Regarding the DBS intervention situation, three different architectures for the 
electrode implantation could be described depending on the system followed: frame-based 
operation, frameless operation or iMRI Guided operation. Throughout the process, errors are 
dragged on with each step and, although at first it could be a very small error, as it is dragged and 
accumulated, it ends up being a significant error.  
In frame-based operations, which is the current technique followed in the Hospital Clínic to 
accomplish the electrode implantation, different errors could appear and could propagate during 
the whole process and they are reviewed in Figure 5. Firstly, when registering CT and MRI 
images, there may be technical or image fusion errors. In the registration and planning process, 
technical errors as well as human errors could appear. Finally, when proceeding in the surgical 
intervention to the burr hole opening a brain shift error exists as well as in the electrode 
implantation, mechanical and human error could be present. Finally, in electrode fixation the lead 
migration error is a possibility. Once all the process is fulfilled, the targeting error is achieved. [17] 
2.2. STATE OF THE ART TECHNOLOGY 
DBS is a precise method of neuromodulation technology which was certified as a medical 
treatment of medication-refractory PD by the Food and Drug Administration (FDA) in 1997. This 
evidences that DBS is a recent technology implemented in neurosurgery. Hence, DBS is a 
rapidly-growing area of endeavour. DBS technology has been developed from cardiac 
pacemakers. 
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Figure 5. Propagation of uncertainty in the implantation of DBS electrodes in a frame-based 
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On 1950, the insight of neuromodulation using high-frequency and pulsatile stimulation for PD 
therapy was firstly detailed by Hassler; where patients affected by Parkinsonism were stimulated 
by wires inserted in the GPi. Hassler brought to a close that high-frequency stimulation, on the 
range of 25-100 Hz relieved tremor. Since that moment, over 100.000 patients worldwide have 
been conducted implantation with DBS systems, notwithstanding, the mechanism is still a matter 
of debate in both medical and research fields. [18] Lawrence Pool, a neurosurgeon from 
Columbia University, is known to be the first implanting an electrode, specifically in a woman with 
depression and anorexia. [19] 
DBS is nowadays being implemented as a treatment in a wide range of disorders, including 
epilepsy, dystonia, and severe obsessive-compulsive disorder. The aforementioned clinical 
applications might differ during the following years as many clinical trials are testing efficacy and 
safety of DBS on other pathologies like severe treatment-refractory major depressive disorder, 
depression, delaying Alzheimer’s disease and chronic pain. 
Electrode configuration and stimulation 
Configuration. Electrodes used in deep brain stimulation techniques depict different 
configurations and stimulations. With reference to the common DBS electrode configuration, 
which emerged on 2002, the conventional quadripolar electrode has four stimulating contact at 
the tip of the probe. This cylindrical configuration may produce a spherical electrical field shaped 
along the z axis of the lead, and it may spread outside the desired target producing side effects.  
In 2015, directional leads appeared and allowed a directional steering and control of the electrical 
field, reducing the possible adverse effects as it enhanced the therapeutic window. Directional 
leads, instead of presenting a cylindrical configuration, uses radially segmented contacts. Finally, 
the eight lead contact electrode with multiple independent current control, which has the ability of 
having different stimulation parameters in each electrode contact. [19] [20]  The different type of 
configurations can be observed in Figure 6. 
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Figure 6. Deep brain stimulation electrode configurations [17] (A) Conventional 
quadripolar electrode. (B) Directional DBS electrode. (C) Eight contact electrode
A B C
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Stimulation. Depending on the DBS electrode configuration proposed, stimulation can vary 
(Figure 7). Firstly, in the conventional quadripolar electrode, a unipolar or bipolar stimulation could 
be computed, as well as an interleaving stimulation. In the case of a unipolar stimulation, the 
current will be directed from the battery to one electrode contact, or conversely with a rapid 
alternating. With respect to bipolar stimulation, the current will be flowing from between the 
different electrode contacts, one acting as an anode and the other as a cathode. Finally, in an 
interleaving stimulation the current is alternated with different stimulation configurations.  
Concerning directional DBS electrodes, the current can be directly targeted or shaped depending 
on clinical symptoms or anatomy. Lastly, referring to an eight contact electrode configuration, the 
multiple level stimulation is applied, allowing different neural targets to be stimulated across the 
electrode trajectory. 
Innovation in electrode and IPG design 
Future challenges comprising the DBS field entails research for physiologists, engineers and 
clinicians. In Table 1, one can observe the main improvements DBS could suffer on the following 
decades, determined by if they are affecting the electrode or the neurostimulator.  
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Table 1. Future challenges involving DBS
FUTURE CHALLENGES
ELECTRODE





Adaptive DBS and closed-loop algorithms
Rechargeable battery
NON-INVASIVE DBS
Temporally interfering electric frields
Low intensity pulsed ultrasound
Figure 7. DBS electrode types of stimulation [17] (A) Unipolar and bipolar stimulation. (B) Interleaving 
stimulation. (C) Directional stimulation. (D) Multiple level stimulation
A C DB
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Electrode improvements. Thorough the upcoming years, software and hardware DBS system and 
implantable devices will need adjustment. One of the most considerable improvements that could 
occur is to ameliorate the targeting accuracy of the DBS lead and to enable a larger amount of 
patient-specific modelling of the electrical field within the patient’s brain, as DBS electrodes are 
frequently positioned adjoining important functional brain structures and the outcomes of the 
electrical field ejected could cause numerous side effects.  
Target accuracy is fundamental in DBS procedures, alongside enhancement in high-technology 
imaging, which could manage to directly image small nuclei and subnuclei (main targets), helping 
localisation. [21] 
A further electrode improvement could be the inclusion of DBS leads containing radially-
segmented or multi-prong electrodes, which have the capacity of generating a more precise 
electric field around the DBS lead. [21]  Electrode design is fundamental in terms of innovation of 
DBS. Currently, the most used DBS electrodes present a quadripolar configuration, four equally 
space contacts at the tip of the probe. A quadripolar configuration allows the electric field to be 
shaped along the z axis, whilst in 2015 directional electrodes appeared presenting a more 
versatile shaping of the electric field. Electrode wires are made of platinum-iridium connectors of 
nickel alloy are encased in a polyurethane sheath. [19] 
IPGs improvements. Moving onto the neurostimulator improvements, closed-loop strategies could 
provide the patient with a more stabilised therapy by programming the IPG. The search of 
biomarkers is fundamental in order to achieve a close-loop, as DBS must be able to feed the 
information back into a control algorithm. In PD, the biomarker is thought to be a beta-band 
activity (13-35 Hz) present in the STN since the signal is abolished by dopaminergic and DBS 
therapies.  
The introduction of rechargeable batteries would be also an improvement as revision surgeries 
for replacing IPG would be reduced, although they would not be completely eliminated. 
Rechargeable batteries include an increase in technologies such as complex software algorithms. 
Rechargeable batteries would cause a great save in a patient undergoing a chronic DBS therapy, 
as the cost of an IPG ranges between $12.500 and $26.000. Another way of reducing associated 
costs with DBS therapy is to improve the outcome of the treatment and reduce surgery 
complications, which could be an infection, accuracy errors, within others. [21] 
Figure 8 exhibits, in a comparative graphical representation, the main differences between the 
current DBS system available (8.a.) and the predicted DBS system (8.b.) regarding the 
introduction of some innovation which has been specified beforehand. 
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Despite all the improvements mentioned beforehand, one of the main challenges which have 
been recently studied by the Massachusetts Institute of Technology and the Harvard Medical 
School is accomplishing a noninvasive methodology of DBS by non-implanted electrodes placed 
on the scalp. [21] Currently, these experimental studies have been taken place in mouse models.  
This approach could transform the procedure to a noninvasive one, reducing possible risks and 
being more accessible to patients as the cost would also be reduced. In this specific study, two 
high-frequency electrical currents are generated using electrodes in the scalp, that they differ by a 
very small amount: one frequency of 2.0kHz whilst the other is of 2.01kHz. Both frequencies have 
a receiver and an emitter electrode. These high-frequencies lead to neurons not being able to fire 
action potentials, but their currents will interfere with one another and they will finally generate a 
small region of low-frequency current  (in this specific case, of 0.01 kHz) deep in the brain that 
neurons are able to follow, hence the high-frequency is cancelled (Figure 9). [23] [24] 
12
Figure 9. Possible non-invasive DBS stimulation [23]
Figure 8. (a) Current DBS system compared with a (b) predicted DBS system [19]
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Other studies carried out by Hui Zhou et al, from the University of Chinese Academy of Sciences, 
have concluded that noninvasive ultrasound DBS is able to treat PD in mice. Ultrasounds are 
mechanical waves with the ability to evoke neural activity, and low-intensity pulsed ultrasound 
finally showed the capacity of enhancing motor function in a mouse model. [25] 
DBS Stereotactic systems 
For DBS implantation, different stereotactic systems can be used. These systems can be 
classified into three main groups, frame-based, frameless and the iMRI-guided systems (Table 2). 
The gold standard apparatus in functional neurosurgical interventions from decades has been the 
frame-based stereotactic system, based on a frame which fixes the patient’s head and it is 
coupled with navigation software. Frame-based stereotaxis includes the Leksell system (Elekta 
Instruments Inc., Sweden), the Zamorano-Dujovny system (Stryker-Leibinger Inc., Germany), the 
Riechert-Mundinger system (Inomed Pte Ltd., Germany), the Cosman-Roberts-Well system 
(Radionics Inc., USA), Sugita system (Mihuzo Medical Co Ltd., USA) and the Neuromate robot 






Leksell Elekta Instruments Inc. Sweden
Zamorano-Dujovny Stryker-Leibinger Inc. Germany
Riechert-Mundinger Inomed Pte Ltd. Germany
Cosman-Roberts-Well Radionics Inc. United States
Sugita Mihuzo Medical Co Ltd. United States
Neuromate robot Renishaw Inc. United Kingdom
FRAMELESS 
SYSTEM
NexFrame Image-Guided Neurologics Inc. United States
STarFix microTargeting Plaform FHC Inc. United States
Stealth Autoguide Medtronic Inc. Ireland
iMRI GUIDED 
SYSTEM ClearPoint SmartFrame MRI Interventions Inc. United States
Table 2. Model and enterprise of the three stereotactic systems available
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Nonetheless, the use of frameless systems has increased over time. Frameless systems 
include NexFrame (Image-Guided Neurologics Inc., USA), the STarFix microTargeting Platform 
(FHC Inc., USA) and the Stealth Autoguide (Medtronic Inc., Ireland). Finally, iMRI-guided 
systems, in this case, ClearPoint SmartFrame (MRI Interventions Inc., USA) have also been 
gaining ground in recent years. 
Some of the lasts stereotactic systems introduced in the market where the Neuromate robot and 
the ClearPoint SmartFrame, making DBS implantation a more complex procedure but presenting 
better targeting accuracy (TE). [21] The Neuromate robot (Figure 10) is a robotic arm with five 
degrees-of-freedom which is coupled into a personal computer-based kinematic positioning 
Software system. [26] [27] 
ClearPoint SmartFrame (Figure 11) is based on real-time MRI guidance as a minimally invasive 
procedure during implantation or for surgical planning. [28] This system uses a SmartFrame 
trajectory device which enables the MRI-guided alignment and implantation of the depth 
electrodes. ClearPoint is also assembled into specific software with the aim of guiding the 
physician. 
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Figure 10. Neuromate robot involved in surgery planning (right), 
assembled software system (left) [27]
Figure 11. ClearPoint SmartFrame architect [28]
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The founded TE in the Neuromate Robot has been of 0.86 ± 0.32 
millimetres (mm), whereas the iMRI-guided system showed a TE of 
0.6 mm. In the Leksell stereotaxis system, reviews have found out a 
TE varying of 3.00 mm to 1.3 mm. Similar results have been found in 
frameless systems. Nonetheless, neurosurgeon’s proficiency and 
expertise in DBS implantation, different usage of peripheral 
equipment and devices and the hospital could make the TE fluctuate. 
[17] 
Finally, Stealth Autoguide cranial robotic (Figure 12) assures 
continuous real-time visualisation as well as a high precision in 
stereotactic surgery. One of the main characteristics is that it presents feedback and robotically-
assisted movements which allow the surgeon to align quickly and accurately the surgical plans for 
the procedure. [29] 
In stereotactic surgery, neuronavigation (both hardware and software) is coupled with surgical 
planning and with the procedure. Neurosurgeons at the Hospital Clínic work with the 
StealthStation™ S8 Surgical Navigation (Medtronic Inc., Ireland).  Procedures are achieved with 
frame-based systems (Leksell) and with Stealth Autoguide.  
In stereotactic surgery, it is considerably important the use of intraoperative image, such as MR 
and CT. In stereotactic procedures, CT images assure the proper placement of the leads in the 
STN or other targets. O-Arm Surgical Imaging (Medtronic Inc., Ireland) is a mobile CT system 
which is intraoperative 2D or 3D imaging system integrated in the operating room used in 
Hospital Clínic. [30]  
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Figure 12. Stealth 
Autoguide robot coupled 
with navigation [29]
Ilianne Guillot Vidal 
Biomedical Engineering
3. MARKET ANALYSIS 
3.1. MARKET SECTOR 
The market sector contemplated in this project is the one related to deep brain stimulation 
technology as well as neuroimaging. Consequently, the different major brands focused on 
neuromodulation are detailed and described below. Neuromodulation is defined as the alteration 
of nervous activity by targeting a stimulus in a specific nervous structure and is comprised by 
non-invasive methods as well as invasive methods, which are differentiated depending on the 
type of stimulus performed: electrical or magnetic. In this project, the relevant neuromodulation 
procedure is deep brain stimulation, being an invasive technique by terms of applying an 
electrical stimulus to the desired target. [31] The three main companies are Boston Scientific 
Corporation (Marlborough, MA, USA)), Medtronic Inc. (Dublin, Ireland) and Abbott Laboratories 
(Abbott Park, IL, USA), and their principal products are specified underneath.  
Boston Scientific Corporation presents all the devices needed to perform deep brain stimulation, 
such as electrodes and accessories, the neurostimulator and a software planner (GuideTM DBS 
Simulation) using pre-operative MR images and post-operative CT and they all are categorised 
by the name VerciseTM. [32] Regarding the VerciseTM DBS Lead, it presents an eight ring contact 
lead with multilumen tubing and filar conductor cables inside, whilst the Vercise CartesiaTM 
Directional Lead is characterised by eight contacts configured into two ring electrodes and two 3-
segment electrodes, as well as a radio-opaque marker, which is mentioned in the product detail 
description. [33] 
Figure 13 displays the main differences between the VerciseTM DBS Lead (13.a) and the Vercise 
CartesiaTM Directional Lead (13.b). The principal distinction between them is that DBS lead has a 
linear eight contact lead, and the Directional Lead has one dome tip contact, six segmented 
contacts and finally one ring contact. Nevertheless, they are both composed by polyurethane in 
the outer jacket tubing, acting as an insulator, and of platinum or iridium in contact material as 
these materials present a minimal toxicity as well as being conductive. 
Regarding Medtronic Inc., the PerceptTM PC Neurostimulator is used in DBS for PD. [34] Different 
models of brain neurostimulation leads exist, specifically the Medtronic 3387 (standard electrode 
spacing), Medtronic 3389, which is the compact electrode spacing and the mostly used and lastly 
Medtronic 3391, comprising large electrodes and wide spacing. [35] [36] 
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Figure 13.  (a) Boston Scientific VerciseTM DBS Lead. (b) Boston Scientific Vercise CartesiaTM 
Directional Lead [33]
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Medtronic Inc. also has commercially available surgical imaging systems which are essential to 
ensure a good outcome of surgery. The O-armTM system constitutes of an intraoperative two-
dimensional fluoroscopic and three-dimensional imaging system. It is compatible with the 
Software StealthStationTM navigation, and it’s main advantage is that it ejects the require to send 
the patient to the hospital radiology centre. [30] 
Finally, St. Jude Medical (Minnesota, USA), later acquired by Abbott Laboratories (Illinois, USA), 
was the first medical company to develop a constant current device for deep brain stimulation. 
The DBS leads from St. Jude / Abbott are the Infinity DBS lead which are characterised for having 
4-contact quadripolar electrodes (Infinity 4-channel lead 6166 & 6168 and Infinity 4-channel lead 
6167 & 6169) and 8-contact directional electrodes (Infinity directional lead 6170 & 6172 and 
Infinity directional lead 6171 & 6173). The Abbott Infinity IPGs present compatibility with 
Medtronic DBS leads. It is important to emphasise that the Abbott Infinity DBS leads are not MRI-
compatible. The diameter and contact spacing depend directly on the model. [36] The Abbott’s 
Infinity DBS System is the first wireless iOS software mobile platform offering a personalised 
treatment minimising adverse effects. [37] 
Table 3 comprises the main physical difference between the different DBS electrode models 
precise beforehand of the three main enterprises. 
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DEEP BRAIN STIMULATION ELECTRODES
Boston Scientific
VerciseTM Linear 8-Contact Lead






Abbott / St. Jude
Infinity 4-channel lead 6166 & 6168
Infinity 4-channel lead 6167 & 6169
Infinity directional lead 6170 & 6172
Infinity directional lead 6171 & 6173
Table 3. Currently commercially available electrodes for DBS [36]
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Other companies such as PINS Medical, SceneRay and Nexstim offer distinct types of DBS 
electrodes, however, they have not been contemplated in this project. NeuroPace Inc. and Aleva 
Neurotherapeutics SA are emerging companies which are innovative in the market for DBS 
devices. [37] 
3.2. FUTURE MARKET PROSPECTIVE 
Over all these past years, life expectancy has exponentially increased, as better medical care and 
better living conditions have played a fundamental role. Additionally, life expectancy has suffered 
an important growth due to the decrease of infant mortality across the world. As people reach an 
older age, the prevalence of neurodegenerative diseases has increased considerably together 
with surgical procedures for PD, and since society has become aware of neurological diseases 
and their long-term treatments, such as deep brain stimulation, Gran View Research Inc. 
estimates that the market size by product of DBS will be raised in the forecast period. [37] A 
further element that plays a major role in the market is the constant technological advancement, 
such as robot-assisted implantation, improving microelectrode design, rechargeable IPGs, within 
others mentioned on section 2.2. beforehand. 
The insight of the future of DBS comprises a less invasive, safer and more personalised and 
effective technique; eliminating the anterior-wall chest IPG and extension cables, increasing the 
battery life of the smaller cranialised IPG, together with electrodes able of sensing and 
stimulating. The improvement of sophisticated imaging techniques such as > 3 Teslas (T) MRI 
systems will enhance the identification of brain structures and to validate the possible 
physiological effects of the electric current in the brain target. [18] Nevertheless, being such an 
emerging technology, it is important to consider the ethical, security and privacy effects that this 
methodology and the respective technological advances entail. 
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4. LEGISLATION AND REGULATION 
This project is based on an accuracy assessment of lead placement in stereotactic surgery 
regarding PD. As it has been fully developed in Barcelona, Spain, the legal requirements taken in 
to account follow the Spanish legislation.  
Firstly, as the studio is based on real data from patients which were acquired in the Hospital 
Clínic of Barcelona, the information has to be preserved by the Ley Orgánica 3/2018, de 5 de 
diciembre, de Protección de Datos Personales y garantía de los derechos digitales. As it can be 
seen in Disposición adicional decimoséptima [38] focused on health data treatment, the study will 
be allowed if the data used are for biomedical research purposes and if all of them have been 
previously anonymised without being able to obtain personal information about the patient from 
them. 
Deep brain stimulation, in this particular project, consists of the introduction of two electrodes in 
the subthalamic nucleus and a subcutaneous neurostimulator in the anterior chest wall. Hence, 
these devices must fulfil the European Commission legislation, specifically the directive of Council 
Directive 90/385/EEC regarding Active Implantable Medical Devices. According to the European 
Commission, an active medical device is defined as “any medical device relying for its functioning 
on a source of electrical energy or any source of power other than that directly generated by the 
human body or gravity” whilst an active implantable medical device, “any active medical device 
which is intended to be totally or partially introduced, surgically or medically, into the human body 
or by medical intervention into a natural orifice, and which is intended to remain after the 
procedure”. [39] As a result, design and construction of the electrodes and the pulse generation 
will have to follow the detailed requirements, alongside being identified with the CE mark. 
Nonetheless, the 26th of May of 2021 a new European Union directive has been implemented on 
the clinical investigation and sale of medical devices for human use, the Regulation (EU) 
2017/745. It came into force the 25th of May of 2017, and it concerns both medical devices and 
active implantable devices. [40] 
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5. CONCEPTION ENGINEERING 
All the solutions studied in order to compute the vector assessment have been comprised in 
Table 4. The study of solutions describes into further detail all the approaches which could be 
proposed to accomplish the objectives set for this study.  
5.1. STUDY OF SOLUTIONS 
 5.1.1. DATA ACQUISITION AND PREPROCESSING 
In order to obtain and compute the preprocessing of the patient’s data, including the coregister of 
a preoperative MRI and a postoperative CT and the further coordinate acquisition for the 
accuracy assessment, three different programs have been studied. 
StealthStation S8 is a software application developed by Medtronic Inc. designed to facilitate the 
neurosurgical navigation and the planning of interventions, both cranial and spinal. It is a software 
which displays a high number of applications and characteristics, as it presents automatic 3-D 
segmentation tools, anatomical and structural visualisations, surgical planning approach with 
virtual craniotomy and virtual endoscope tools and image merging from a wide range of imaging 
systems.  
The main advantage of StealthStation S8 is that it is a very graphical and intuitive interface to 
use, facilitating understanding. On the other hand, obtaining the coordinates is a very simple 
process once the commissures are determined and the brain is divided into the two hemispheres. 
It also has the option of viewing the atlas superimposed to check the anatomical region where the 
electrodes are located. Conversely, as being a Medtronic program that is associated with all the 
machinery used for navigation in the operating room, it is a very costly and expensive software, 
which is only available at the Hospital Clínic or in those clinics that have an agreement with the 
company. [41] 
SOLUTIONS STUDIED
Data Acquisition and 
Preprocessing
• Stealth Station S8 Medtronic Inc. 







Table 4. Study of solutions for the fulfilment of the study
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Figure 14 displays the main screen of the software with the reference electrodes obtained from 
the atlas, and the placed during surgery. On the right, the coordinates are shown. 
Lead DBS Matlab is a free Matlab toolbox focused on DBS electrode reconstructions and 
computer simulations based on postoperative MRI and CT imaging. Lead DBS allows the user to 
locate and visualise in a 3D environment DBS electrodes, taking into account a high number of 
subcortical atlases and whole-brain parcellations ceded by several authors. In addition, both 
functional and structural whole-brain connectome analyses could also be computed.  
The program is not as intuitive as the mentioned beforehand, and one must have a notion of 
programming and neuroimaging to understand and use it correctly. Nevertheless, the process of 
three-dimensional modelling of the electrodes was not automated and depended on the author 
and this can lead to a large margin of error. On the other hand, DBS electrode simulations could 
be performed but the relevant coordinates were not obtained. [42] The visualisation of the three 
dimensional modelling accomplished by the toolbox is shown in Figure 15. 
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Figure 14. StealthStation S8 Medtronic main screen
Figure 15. Lead DBS Matlab 3-D modelling of electrodes [42]
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BRAINLAB Elements is a software program designed by Brainlab which includes multiple 
clinical specialties, such as interactive and automatic segmentation applications regarding image 
guided surgical planning. DBS electrode 
placement as well as stereotactic planning can 
be computed (Figure 16), and all the 
coordinates and data needed for this study are 
achievable. Nonetheless, it is also a very 
expensive program and it has compatibility only 
with the electrode models developed by Boston 
Scientific, thus in the Hospital Clínic of 
Barcelona stereotactic surgeries are performed 
using Medtronic electrodes. [43] [44] 
 5.1.2. PROGRAMMING ENVIRONMENT 
In order to accomplish the accuracy assessment including the statistical analysis, different 
softwares can be used: MATLAB, RStudio and Python. Each of them are detailed below. 
MATLAB is designed presenting different toolboxes for data analysis, image processing, 
visualisation, within much others.  It is a computing environment which facilitates iterative analysis 
as well as design processes, and it expresses the mathematics of matrices and arrays directly. 
[45] Nonetheless, for its use an annual license of a very high cost is required, and this is given by 
the University of Barcelona itself. 
RStudio uses the programming environment of R, which is specially focused on statistical 
analysis and graphical representation of them in a data science environment. RStudio is a free 
and open source software and includes a big number of R packages for data science, Machine 
Intelligence, interoperability between Python and R, and much others. [46] 
Python is a programming software characterised by its efficiency, general-purpose and flexible 
environment. It is one of the most popular programming languages and it also includes packages 
such as NumPy, Matplotlib or SciPy. It is an open source software which makes the program 
accessible to every individual.  
5.2. PROPOSED SOLUTIONS 
Once all the solutions have been thoroughly studied comparing all their characteristics and 
applying them to the objectives of this study, the following solutions have been selected. 
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Figure 16. Brainlab Elements Stereotaxy planning [44]
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The programming environment selected has been MATLAB, as it presents a facility with 
mathematical expressions as well as in the relevant statistical study and graphical 
representations. As it is only necessary to calculate the relevant values as well as represent 
them, it does not require external persons to have the license, as the author has it. 
Moreover, data acquisition as well as pre processing and obtaining all the coordinates necessary 
to fulfil the accuracy assessment were obtained using StealthStation S8, the Medtronic cranial 
and spinal surgical planning software available at the Hospital Clínic of Barcelona. Considering 
that it is a very intuitive and very graphical program, it makes the process of obtaining the 
necessary data quick and simple.  
Originally the author wanted to use Lead DBS Matlab, whereas it is a free open source program 
accessible for anyone who wishes to access it, alongside being a toolbox of MATLAB, hence it 
requires the license of MATLAB. Nonetheless, finally it was not chosen as it does not present the 
coordinates in a precise way, due to the dependency of a lot of knowledge of brain’s anatomy of 
the author, and left a fairly large margin of error. 
Lastly, the BRAINLAB Elements program could have been used, however, since the electrodes 
implanted at the Hospital Clínic of Barcelona correspond to the Medtronic company, it was 
considered that the study would be more accurate if the preprocessing was also carried out with 
the company’s software. 
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6. DETAIL ENGINEERING 
As it has been mentioned beforehand, this study consists of the co-registration of preoperative 
MRI images and postoperative CT images and data acquisition to obtain the x, y and z 
coordinates (AC-PC coordinates) of the electrode located specifically in the STN, which have 
been acquired for both hemispheres.  
The methodology followed has used a population of 76 patients with Parkinson’s disease who 
have undergone a STN-DBS at the Hospital Clínic of Barcelona from 2015 to 2020, whose brain 
electrodes have been implanted with verification of intraoperative imaging, under general 
anaesthesia.  
Secondly, by terms of using MATLAB and the coordinates, the vector error is calculated and an 
accuracy assessment is computed. The results are graphically represented in two scatter plots 
and the regression line, as well as the equation, are found.  
Finally, the results are divided into the statistical analysis, consisting of the mean, the standard 
deviation and a Student T-test. To conclude, a clinical appraisal is analysed, using each patient’s 
medical histories once they have been previously anonymised. 
6.1. DATA 
Referring back to the population used for the study, the preoperative MRI images as well as 
postoperative CT images once the STN-DBS was accomplished has been utilised of 76 patients 
in the temporal space of 2015 to 2020. All the data was previously anonymised to ensure that no 
relationship could be established between the images and the clinical information used of the 
patient with his name or other personal data. Likewise, medical histories have been used.   
Therefore, the historical cohort of conscious operated patients under local anaesthesia has been 
excluded in this project, in which the intervention performed entailed a series of electro-
physiological and clinical tests to verify the correct positioning of the electrodes. This was 
essential during the period 1994-2014, in which the stereotactic intraoperative image integrated 
with the neuronavigation systems was not available.  
The benefits of operating on the patient under general anaesthesia are important and remarkable, 
both for the patient undergoing the intervention as well as for the healthcare system of the 
country. Some of these benefits are precised on Table 5. 
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6.2. CO-REGISTRATION AND COORDINATES ACQUIREMENT 
Co-registration techniques have been fulfilled using StealthStation S8 designed by Medtronic Inc, 
which is available at the Hospital Clínic of Barcelona. The desired images of each patient are 
selected and co-registered automatically by intrinsic algorithms of the software.  
The company program is intuitive and its main menu is shown in Figure 17. It is composed of 8 
characteristics which are specifically detailed in Table 6: CA-CP, Plans, Annotations, Plan overlap, 
Atlas, 2D views, 3D view and designs. In this study, the most used were CA-CP to obtain both 
commissures, Plans to acquire target points and the entry points coordinates and 2D views to 
control the coregister between CT and MRI. 
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Figure 17. Menu available at StealthStation S8 in “Stereotactic DBS Frame”
Benefits of a STN-DBS surgical procedure carried 
under general anaesthesia
Prevents the patient’s suffering
Eliminate the need to withdraw all medication in order to 
assess symptomatology
Eliminate the need to introduce electro-physiological 
recording microelectrodes, which are more dangerous as 
they present a sharper structure
Reduces duration of the intervention, which is directly related 
to the risk of infection, within others.
Shortens hospital admission time
Table 5. Benefits of the surgical intervention of STN-DBS under general anaesthesia
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Furthermore, once the co-registration is verified by the system and by the author, the 
establishment of the anterior commissure (AC) along with the posterior commissure (PC) must be 
performed to obtain the desired AC-PC coordinates. Three images are imported into the software: 
a postoperative CT, a T1 section of MRI and FLAIR T2 MRI.  
This process consists of the location by the author of each structure, leading to a small margin of 
error, as the coordinates refer to the AC-PC line in the axial plane. The AC-PC line is the line 
connecting the anterior and posterior commissure, separating the brain into two equal parts; in 
two different hemispheres. The origin of the AC-PC line comes from the ventriculography. The 
AC-PC line can be certainly observed in Figure 18. 
Thereupon, firstly both commissures are detected and once they are finally selected and the 
intermediate plane is also determined, the software calculates the AC-PC distance. To detect the 
location of the commissures, it is only required to use the T2 FLAIR image of the patient's MRI, as 




Used in order to define the AP and the PC, as well as the 
intermediate line and the AC-PC distance
Plans
Fundamental tool to implement the planning of the intervention, 
obtaining the theoretical coordinates as well as the real ones
Annotations
To mark a point of anatomy or pathology, and they can be placed 
at the point of navigation in order to mark a location
Plan Overlap Allows you to merge different created plans
Atlas
A fully integrated Schaltenbrand Wahren Atlas and a Talairach 
grid which grant interaction and facilitates obtaining a better 
understanding of the brain’s anatomy
2D views
Two-dimensional viewing of the selected images (CT and MRI) 
and its coregistration, together with having the ability of changing 
some of its imaging properties
3D views Three-dimensional model obtained based on the images
Designs
You can adapt the interface and choose the preview, how many 
screens, if you want them to be axial planes, within others. It 
even permits the design of an interface which is more 
comfortable
Table 6. Software characteristics and its main function 
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Once the stated process is achieved, the methodology proceeds to the detection of the DBS 
electrodes. For this case, the T1 co-registered with the CT scan is used, so the anatomical 
structures with the electrodes superimposed on them are witnessed. It is worth emphasising that 
an image from a CT scan presents many artefacts, especially in terms of metal objects such as 
the electrodes. That is why it will be necessary to raise the level of the image to obtain the most 
faithful electrode possible to reality, with a diameter of 1.27mm with regard to the model used, the 
Medtronic 3389. Once this procedure has been finalised, the coordinates of the electrodes will be 
obtained in the "Plans" section, concerning the Schaltenbrand AC-PC line. 
In neurofunctional interventions, the brain coordinates used are named the AC-PC coordinates. 
Figure 19 shows the coordinates with respect to the commissures and the target, where a 
localiser box is placed on the frame and it generates a coordinate system calculated in reference 
of the AC-PC line. This system corresponds to the Talairach atlas, and assuming that the brain 
retains the individual shape and size. [48] [49] As aforementioned, the landmarks are the AC and 
the PC, and the coordinate axes are defined according to these characteristics: 
• The origin of the coordinate 
system is in the AC. 
• X-axis (lateral): It goes towards 
the right side of the brain. 
• Y-axis (antero-posterior): It goes 
towards the front of the brain. 
• Z-axis (vertical): It goes towards 
the top of the brain. 
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Figure 18. AC-PC line seen in an axial MRI image [47]
Figure 19. AC-PC coordinates and base unit [48]
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In general conditions, the atlas states that the coordinated in the right hemisphere for the STN are 
located in the x (lateral), y (antero-posterior) and z (superior) of 12mm, -4mm and -4mm, whereas 
in the left hemisphere the coordinates x, y and z respectively are of -12mm, -4mm and -4mm.  
The software has a built-in atlas, a Schaltenbrand-Wahren Atlas alongside a Talairach grid, and 
therefore once the location of the electrode has been selected following the co-registration of the 
images, the theoretical electrode of the atlas can be superimposed and the difference can be 
seen visually. The software also has the option to overlay the atlas and validate the anatomical 
region where the electrodes are located.  
The Schaltenbrand-Wahren Atlas, in blue colour, overlaid onto the coregistered image is exhibited 
in Figure 20. The brain image observed corresponds to a T2 FLAIR MRI, and the small grey 
artefacts shown correspond to the CT image, specifically to the DBS electrodes. The use of the 
Schaltenbrand-Wahren Atlas allows the visual and easy anatomical location of the electrodes as 
well as of brain structures. In this specific case, it serves to verify that the electrodes have been 
correctly implanted in the STN, the desired target. 
Additionally, Figure 21 comprises the co-registration of T1 MRI and CT scan and the location of 
the real electrodes and the theoretical electrodes. The images are seen in coronal (top left), 
sagittal (top right), axial (bottom left) and probe’s eye (bottom right). The blue and the orange 
electrodes correspond to the real implanted electrodes during the intervention, for the right and 
the left hemisphere respectively. Contrariwise, the pink and green electrodes refer to the 
theoretical electrodes following the atlas’ coordinates.  
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Figure 20. Schaltenbrand-Wahren Atlas overlaid with the coregistered image of MRI T2 and CT
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Following the same procedure mentioned, the coordinates of the entry points can be found, since 
the CT image is composed of many slices, it can be observed exactly from which point in the 
brain the electrode enters from the stereotactic framework. Thus, the software will not only place 
the electrode on the required target, the STN, as it locates the correct entry point, hence marking 
the actual trajectory.  
To achieve the deviation error, it is necessary to use the plans made by the neurosurgeons prior 
to the intervention, merge them, and calculate the differences. This process was intended to be 
followed for the entire study population but was not possible as the available data was erased 
before the study was computed. 
All the methodology is accomplished with each patient and all the data, both entry points and 
target points, are saved in a file. Lastly, each patient will have twelve coordinate values. Six will 
correspond to the entry points, which have finally not been used in this study, and the other six to 
the target points, likewise for the respective brain hemisphere. 
6.3. ACCURACY ASSESSMENT 
To accomplish a validation of the current surgical technique, an accuracy assessment to assess 
electrode placement has been fulfilled using MATLAB (see Annex) by terms of calculating the 
vector error to obtain the targeting accuracy in all the data acquired. [50] As mentioned earlier, the 
deviation off trajectory was intended to be studied, however, the available data was erased. 
I. The vector error is the distance between the position of the centre of the target DBS 
electrode contact and the desired target location which is determined by the euclidean 
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Figure 21. Representation of the real (blue and orange) and the theoretical (pink and green) electrodes
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distance between these two specific points. The vector error corresponds to the true 
accuracy. 
II. The deviation off the trajectory describes the perpendicular distance from the target 
electrode to the planned trajectory only in the axial plane, hence the deviation in the 
radial plan. The off-trajectory error are more complex for them to be corrected.  
 
Figure 22 displays a graphical representation in order to obtain a better understanding of the 
vector error and the off-deviation error considering the actual electrode implanted in the 
intervention and the target trajectory, as well as the target coordinates obtained from the plan and 
the atlas.  Moreover, Figure 23 exhibits the different definitions of TE, in this case, established the 
VE as d (Euclidean error) and r the trajectory error. 
 
30
Figure 22. Vector error (v) and Trajectory error (T) representation [50]
Figure 23. Graphical representation of different definitions of TE [17]
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 6.3.1. VECTOR ERROR 
The vector error (VE) calculation, computed with MATLAB with the code being available at the 
Annex, requires knowledge of the real x, y and z coordinates and also of the theoretical 
coordinates obtained through the atlas. The atlas’s coordinates corresponding to the STN for both 
hemispheres, as previously stated, are outlined in Table 7. 
Once knowing the theoretical coordinates, the author proceeded to the acquisition of real data 
with the methodology mentioned in the section above. To calculate the VE, performed for each 
patient twice, once for each hemisphere, the data were applied and the value was calculated by 
terms of using Equation 1. 
The VE calculation has been computed using the programming environment MATLAB specified in 
section 5.1. by establishing an iterative loop to perform the accuracy estimation. The data were 
stored in a 76-row, 7-column CSV file, where the rows correspond to the patients and the first 
column to the patient's set number and the other six to the respective target point coordinates for 
each cerebral hemisphere. 
The final result obtained once the equation has been calculated has been saved in a CSV file 
with two columns and 76 rows, one column corresponding to the accuracy of the right 
hemisphere and the other to the accuracy of the hemisphere left one.  
6.4. STATISTICAL ANALYSIS 
Besides the accuracy assessment, a paired Student t-test has been computed in order to provide 
a hypothesis test of the population’s means difference for a pair of samples, which in this case 
are the vector accuracy of the right hemisphere and the vector accuracy of the left hemisphere.  
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SCHALTENBRAND-WAHREN ATLAS’S COORDINATES STN
Right Hemisphere Left Hemisphere
• X: 12.00 mm 
• Y: -4.00 mm 
• Z: -4.00 mm
• X: -12.00 mm 
• Y: -4.00 mm 
• Z: -4.00mm
Table 7. Theoretical coordinates of the STN in both hemispheres 
VE = (x1 − x0)2 + (y1 − y0)2 + (z1 − z0)2 (1)
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Furthermore, both the mean and the standard deviation of each VE has been accomplished. 
Additionally, the absolute averages of each coordinate, regardless of accuracy, have also been 
calculated. 
6.5. RESULTS 
 6.5.1. TARGETING ACCURACY 
The targeting accuracy has been assessed for 76 patients which all have undergone the same 
intervention with the same image guided and image verified technique. Once the results were 
analysed, a study of outliers with above-average values was made and two patients who had the 
target to a brain structure other than STN were discarded, as the electrode had been implanted in 
the VIM and they were not patients with Parkinson’s disease, as they had essential tremor. These 
two patients have been rejected and the relevant graphical representations have been made 
again with the 74 patients who do have the electrodes implanted in the STN and therefore have 
PD. All the coordinates for each patient are specified at the Annex. 
Referring to the right hemisphere, the computed mean of the vector error is of 1.923 mm and it’s 
SD is of 1.107. Further to this, the absolute average of the x axis is of 11.482 mm, the y axis of 
-2.673 mm and the z axis of -3.824 mm. These results regarding are detailed in Table 8. 
The results in Table 8 show that the mean is quite close to the value theoretically obtained by the 
atlas. Thus, the coordinate axis that presents a greater difference in this case would be the Y 
axis, with a difference in absolute value of 1.327 mm. Thus, the largest error rate is that of the Y 
axis representing 33.18% error. Nonetheless, both the x and z axis have a lower error percentage 
which is estimated to be around 4%.  
Moreover, regarding the left hemisphere, the computed mean of the targeting accuracy is of 
2.364 mm, resulting in a value 18% higher and greater than the average accuracy in the right 
hemisphere. On the other hand, the SD for the left hemisphere has a value of 1.065. Regarding 
the real coordinates and it's absolute average, the x axis average is of -10.753 mm, whilst the y 
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COORDINATES RESULT (RIGHT HEMISPHERE)
COORDINATES Atlas (mm) Real Average (mm) Error Percentage (%)
X 12 11.482 4.32%
Y -4 -2.673 33.18%
Z -4 -3.824 4.40%
Table 8. Results regarding coordinates for the right hemisphere, n = 74 
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axis -2.629 mm and the z axis -3.840. The coordinate results of the left hemisphere are specified 
in Table 9.  
The coordinate axis that presents a greater difference with respect to the theoretical value is, 
again, the Y axis. Nevertheless, in the left hemisphere the X axis presents a more remarkable 
difference in comparison with the right hemisphere. 
It is observed that, in terms of coordinate positions, there is a greater difference between 
theoretical and real values in the left hemisphere than in the right hemisphere. Furthermore, Table 
10 shows the results obtained from the mean and standard deviation in both hemispheres. 
The results shown in Table 10 of the TE specify that in the 74 patients who were reviewed and 
analysed in this study, the electrodes were implanted more displaced in the left hemisphere, since 
the averages differ by 0.441 mm. Whether demanding to review the real coordinates and the 
specific value of the respective TE for each of the 74 patients, see the Annexes section. 
The result of the Student t-test gives a p-value of 1.384·10-4. Hence, since it is a p-value which is 
lower than 0.005, it means that this study gives results which are statistically significant. 
Once all the calculations have been performed, one graphical representation in scatter plot mode 
has been computed for the right error vector and another for the left error vector, which are 
respectively Figures 24 and 25. 
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COORDINATES RESULT (LEFT HEMISPHERE)
COORDINATES Atlas (mm) Real Average (mm) Error Percentage (%)
X -12 -10.753 10.39%
Y -4 -2.629 34.28%
Z -4 -3.840 4.00%
Table 9. Results regarding coordinates for the left hemisphere, n = 74 
ACCURACY RESULTS
RIGHT LEFT
Mean (mm) Standard Deviation Mean (mm) Standard Deviation
1.923 1.107 2.364 1.065
Table 10. Results regarding accuracy for both hemispheres, n = 74 
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In the figures, the x-axis corresponds to the error vector and the y-axis to the distance from the 
origin (which would be the AC-PC line as discussed above) to the tip of the electrode. This 
distance is the value of x for each hemisphere. 
Both scatter plots show a similar relationship between the vector error and the distance from AC-
PC, which directly depends on the cerebral anatomy of each patient. It can be seen that they 
follow a similar trajectory, although it is true that in both cases there are certain outliers. These 
outliers may be due to poor identification of the AC-PC line while coordinates were being 
acquired, as it was a subjective process and, if done incorrectly, this was hampered in terms of 
error. 
In the left hemisphere, the cases are spread out but it is estimated that most are between 1.5mm 
and 3.5mm error vector, while in the right hemisphere the data are scattered more evenly across 
the graph covering almost all values. However, the range of the error that comprises most of the 
samples is between 1mm and 3mm, which reflects that this TE is slightly smaller in the right 
hemisphere than in the left. 
 6.5.2. CLINICAL APPRAISAL 
To perform a study of the clinic and the symptoms before and after the intervention, the process 
was performed by setting a threshold of 3 mm, meaning any patient who in one of the 
hemispheres had a VE equal to or greater than 3 mm was included in the study of 
symptomatology. By following this methodology two outliers patients were discarded, where one 
had approximately TE at 6mm, for being patients with essential tremor and having a different 
target to STN, as it was VIM. Hence, the methodology has comprised 26 patients, two of which 
were rejected for having the target in another brain structure, ending with 24 patients exceeding 
the threshold of a VE greater than or equal to 3mm. 
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Figure 24. VE scatter plot for the right cerebral hemisphere Figure 25. VE scatter plot for the left cerebral hemisphere
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In general, all patients experience a fairly sudden improvement before electrode implantation and 
stimulation and afterwards, thus notoriously reducing their motor symptoms which may include 
bradykinesia and tremors. Therefore, DBS surgery improves the quality of life of patients 
because, for example, patients who previously could not walk due to the disease could now do so 
more easily. 
However, it is true that the surgery outcomes depend mostly on the adaptation of each patient, 
and nearly all of them will have to continue with treatment, such as levodopa, for life. 
Nevertheless, there have also been cases where the medication has been withdrawn and the 
patient presents satisfaction and enhancement regarding motor symptomatology.  
As mentioned in the prior "Background" section, the approach to record a longitudinal progression 
of the disease is to follow the UPDRS scale, focusing specifically on Part 3 which copes with 
patient motor assessment.  
In general, a large majority of patients show a good evolution once the electrodes are implanted 
with a reduction in the motor symptoms of PD. Notwithstanding, patients typically continue to 
present dyskinesias, which normally appears after years of medical treatment with levodopa, and 
gait freezing, which are short episodes of an inability to move the feet although having the 
intention to walk. 
  
The most exemplary and enlightening clinical results are as follows: 
• Patient 57 presented an error of almost 5mm, concerning the atlas, in an electrode, and was 
treated because they had a problem with the stereotactic frame during the intervention and 
had to reoperate to reposition the electrode correctly. Once the methodology was followed 
correctly, the patient improved remarkably. 
• With an error of 3.2mm, Patient 87 suffered a bilateral capsular effect and the operation had to 
be repeated to place the electrode in a medial position. 
• Explantation of all the DBS system was accomplished to Patient 21, due to the lack of 
effectiveness presenting an error of 3.2mm in the left hemisphere. Additionally, the device 
presented MRI artefacts that would prevent a correct delimitation of the surgical target. A new 
system was implanted and the patient halted taking any anti-Parkinson’s medication, 
displaying very favourable results with only a little gait freezing. 
• Patient 42 presented an error of 3 in both hemispheres and firstly there was a 
neurostimulatory infection, specifically a serosanguinuous exudate through a surgical wound. 
Thus, another operation was performed which consisted of removing the entire implanted 
system and relocating the entire system. The patient, once the revision surgery was done, 
appeared to have a few dyskinesias and a freezing gait. 
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7. DISCUSSION AND FUTURE RESEARCH 
7.1. DISCUSSION 
The intervention of STN-DBS as a treatment for Parkinson's gives very favourable results for the 
patient, thus decreasing a large majority of their motor symptoms. However, normally the patient 
once undergoing the intervention must continue treatment for PD such as levodopa as not all 
motor symptoms disappear, as well as it could get worse over the years.  
In Figure 26 molecular mechanisms initiated or deactivated by stimulation on basal ganglia 
networks are detailed. It can be observed that in the case of Parkinson’s disease, the inhibitory 
pathways of both the neurons at the substantia nigra pars reticulata (SNr) and substantia nigra 
pars compacta (SNc) are increased, as well as the excitatory pathways of STN. This is because 
the STN receives fewer inhibitory signals from the external globus pallidus (GPe) and hence 
sends greater excitatory signals to the GPi and the SNr. Therefore, there is mostly an increase in 
the pathways, causing decompensation and imbalance.  
In addition, there is a loss of dopaminergic neurons from the SNc to the putamen. On account of 
the incorporation of stimulation with the DBS electrode, some effects that were increased 
previously will result having a decreased behaviour, including the excitatory pathway of the STN 
to the SNr and GPi. Whereas the STN is compensated, the stimuli that will reach the thalamus 
from the GPi and SNr will be balanced and return to their normal behaviour. Anyhow, a significant 
loss of dopaminergic neurons will persist after STN-DBS intervention as seen on 26.c. Stimulation 
serves to balance the STN and therefore compensate for the other excitatory or inhibitory 
pathways.  
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Figure 26. Molecular mechanisms of basal ganglia networks in (A) Normal brain (B) PD brain (C) STN-DBS 
brain after stimulation [48]
A   NORMAL B   PARKINSON’S DISEASE C   STN-DBS
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Thus, during this study, it has been possible to verify that the realisation of the STN-DBS 
intervention through the image-guided and image-verified technique by means of intraoperative 
CT with the O-Arm, used in the Hospital Clínic, very positive clinical results are obtained where 
the reduction of motor symptoms are evidenced. The average TE was 1.923 mm ± 1.107 on the 
right hemisphere and 2.364 mm ± 1.065 on the left hemisphere. However, it is important to point 
out that this technique is not performed in many hospitals in Catalonia, yet almost all centres use 
the microelectrode recording (MER) methodology, used to identify brain structures during the 
intervention as it permits the recording of electrical activity, and each brain structure has a unique 
pattern of it. The principal problem with this technique is that the patient has to discontinue the 
use of all medications prior to the surgery, since it is necessary for the surgeon to observe the 
electrical patterns of the brain structures presenting the disease, and the medication could create 
false negatives and hide a possible difference in pattern.  
MER-guided surgery is also a precise technique and has good results [51], but contrarily it has 
setbacks that are mainly the withdrawal of medication before surgery, as well as the process is 
much longer as performing the electrical registration is dense. On the other hand, the patient is 
usually required to be awake, likewise causing anxiety. These three disadvantages of MER are 
eliminated using the image-guided technique, as the patient may be subjected to the necessary 
medication and also slept under general anaesthesia as the target on the STN is well defined and 
the patient does not need to remain awake.  
This study has fulfilled the primary objective of validating the technique used in the Hospital Clínic 
using intraoperative CT and prior planning. Hereby, the importance of accuracy and precision in 
this type of intervention is evidenced, and it is a field where technological advances are very 
present and are constantly evolving to try to achieve an error as close to zero as possible.  
Still, despite using this technique at the Hospital Clínic and achieving significant results, there 
have been a couple of cases where electrodes were incorrectly implanted with a visible error, and 
the only solution to make the electrodes perform their function is to reoperate the patient. The 
technique is used with the stereotactic framework, and with the boom we are experiencing in 
robotics, a robotic arm connected directly to the neuronavigation system could be implemented in 
the operating room which would obtain the coordinates in real-time and compare them with those 
defined during the planning. It would be a very important advance to use a robotic arm that would 
detect at the time where it is and connect it to the virtual map, thus establishing a correlation 
between the real body and the virtual body. 
Lastly, it is important to emphasise that possible errors may have occurred during the whole 
course of the study. Mostly, errors can appear from the establishment of the two commissures 
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during image processing with Medtronic software. The author does not have the same knowledge 
of brain anatomy as a neurosurgery specialist, which is usually responsible of performing this 
process, and if these commissures are incorrectly established, being the point of origin of the 
coordinates, they could be affected and could change the results. Still, the results are generally 
satisfactory as they present a correlation with the clinic symptomatology of the patient. Other 
errors such as the acquisition of coordinates from patients who did not have PD and had 
essential tremor, thus establishing the point of stimulation in a structure other than STN, have 
been reversible errors as they have been removed from the base of patients.  
7.2. FUTURE RESEARCH 
Considering that this study has focused on the technique currently practiced using stereotactic 
framework and intraoperative CT, this allows for much margin of improvement due to the 
evolution that medical technology is currently undergoing. Different advances in biomedical 
engineering can be applied to obtain more accurate results, such as the use of robotics integrated 
into surgery or artificial intelligence. As mentioned beforehand, the insertion of a robotic arm in 
the operating room that is fully integrated with the intraoperative CT as well as with the 
neuronavigation would eliminate possible human errors when fulfilling the burr hole and also 
possible errors due to the incorrect placement or other problems with the stereotactic framework. 
On the other hand, it would be important to implement an artificial intelligence technique that 
would detect the error of the trajectory as well as the error of the target in real-time. This advance 
could be carried out by placing a positional sensor at the tip of the inserted electrode and 
connecting it directly with the navigation or with some other system in the operating room with the 
aim that it represents the numerical value of the error in real-time, and thus to be able to guide to 
the surgeon during the whole placement. 
Finally, it is significant to acknowledge that during this study the author wanted to perform other 
calculations such as the error of the trajectory and the error of the entry point of the electrode 
which were considerable for the validation of the procedure. Neither could be performed as it was 
necessary to have surgery planning computed by the neurosurgeon and all had been erased from 
the system. Consequently, as future work to substantiate this technique in an entire approach, 
these two methodologies could be followed and analysed.  
In view of the technological advances that will appear in the near future, it is necessary to 
highlight the role of biomedical engineers in order to be able to implement it and think about 
connecting technology with medicine. Thus, biomedical engineering play a very important role in 
the technological evolution within medical and surgical specialties, focusing on improving the 
accuracy and utility of techniques, as well as achieving a procedure where the patient is as 
comfortable as possible. 
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8. TECHNICAL VIABILITY 
The technical feasibility corresponds to a SWOT analysis, studying and detailing both external 
(opportunities and threats) and internal (strengths and weaknesses) factors affecting the project 
and displayed in Table 11.  
8.1. STRENGTHS 
Different strengths have been analysed, which are an intrinsic factor of the project and are helpful 
for such. Primarily, the patients’ data that has been used corresponds to a temporal period going 
from 2015 to 2020, therefore it corresponds to different years, obtaining some heterogeneous 
data and realised with different neurosurgeons. Additionally, the first objective of the study is to 
validate the accuracy of the implantation technique guided exclusively by imaging, which is the 




Data from 2015 to 2020 
Validation of a current technique 
Provide objective arguments of the 
technique with general anesthesia 
The use of neuronavigation and 
planning techniques at the hospital 
Automatic coregistration 
3T MRI Imaging (dedicated 
protocol)
Limited software availability 
Margin of error at the coordinates 
acquisition 
Validation of the system with one 
electrode model 
Retrospective analysis 




Alternative non-invasive process to 
fulfil DBS 
7T MRI imaging 
Improvements in planning and 
navigation softwares 
Implementation of IA for error 
detecting in real-time during the 
intervention 
Establish a correlation with the 
clinical outcome (UPDRS III)
New technological approaches to 
perform DBS interventions 
Authorisation granted by doctors and 
patients
Table 11. Overview of the SWOT analysis 
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this way, objective arguments can be obtained about the image-guided image-verified technique 
with the fully anaesthetised patient. 
Moreover, it is also an important strength to have been able to use the navigation software used 
in the hospital during the day to day to plan surgeries, as well as that it has a built-in co-
registration mechanism, eliminating possible margins of error. On the other hand, in the Hospital 
Clínic, there is a dedicated and specific protocol for this type of intervention, where 3T MRI 
images are taken and used during the intervention, allowing to have standardisation and following 
a very similar methodology for each patient. 
8.2. WEAKNESSES 
Although the study presents a wide number of strengths, it also has important weaknesses to 
consider. First of all, as the software is the one used in the hospital it has limited availability. Thus, 
this is because the program is used by neurosurgeons and is not always available, besides it is 
only in the hospital and the author has to travel there to acquire any data. Moreover, it is a 
program from a private company, and therefore there is no public license. 
A weakness related to a possible error is that the commissures had to be placed subjectively, and 
as the author does not have very extensive knowledge of the brain anatomy, it may not be in the 
most correct place and cause deviations in the coordinates acquirement. On the other hand, the 
validation has been done exclusively considering the Medtronic 3389 model, and this validation 
could be modified with other models from the same company or others. 
Additionally, this project is a retrospective analysis, focused on patients from 2015 to 2020. This 
study could be modified in subsequent years with components that have not been considered 
during the five years included in this study. Thus, there is a limited correlation with the patient’s 
clinic that could be improved with the collaboration of a neurologist. 
8.3. OPPORTUNITIES 
There are a variety of opportunities that this study could benefit from, mainly focused on possible 
improvements to the DBS technique as well as technological incorporations into the procedure. 
For example, the alternative non-invasive process to fulfil DBS could mean a non-invasive 
treatment and preferred by the patient. Moreover, improvements in planning and navigation 
software could ameliorate the TE, together with the introduction of 7T MRI imaging. Besides, 
future research focused on artificial intelligence for error detecting in real-time during the 
procedure could appear. As a continuation of this study, a correlation within the surgical outcomes 
of the implantation could be established with the patient's symptomatology following the UPDRS 
III scale, addressed to the motor symptoms of the patient. 
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8.4. THREATS 
Finally, of the four categories, threats are the least existing as it is a study of a technique that can 
evolve very positively in the near future. Notwithstanding, the principal threat of this study, and the 
DBS techniques, is that authorisation is required both from the doctors and the patients. In 
addition, data protection is very important and therefore the anonymization of all data is 
mandatory. 
On the other hand, with so many technological advances, and with the emergence of new 
technologies to perform these interventions, this study could be neglected as it has only validated 
one procedure which follows a specific protocol: the intervention using a stereotactic framework 
system and the image-guided image-verified technique. 
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9. ECONOMICAL FEASIBILITY 
The theoretical costs have been detailed in order to accomplish this study. The economical 
feasibility has been divided into human resources, software and hardware, as well as some items 
such as CT and MRI scans. 
Within human resources, the salary which has been taken into account of the student is of 20€ / 
hour, and the total amount of hours needed to complete the project is 340 hours. Hence, the total 
cost regarding human resources is of 6.800€. Specifically, the work has been divided into three 
different sections: firstly the educational stage, consisting of 50 hours, where the author did a 
bibliographic research as well as an analysis of the background prior to making the relevant 
analysis. Consequently, the developing stage of the study, which comprises the conduction of 
the entire study, from data acquisition to statistical study and clinical relationship. This process 
entails 150 hours. Finally, the writing and editing stage, covering 140 hours, divided into the 
writing and the oral presentation. 
In the software category, both StealthStation S8 and MATLAB have been contemplated. The first 
software mentioned, as it corresponds to Medtronic, hence a private company, it presents a really 
high cost. Nonetheless, for this project, the software has been provided by the Hospital Clínic of 
Barcelona. On the other hand, MATLAB requires an annual license, and in this case is provided 
by the University of Barcelona to all the students, as the author is.  
Finally, StealthStation S8 as well as the private computer, a MacBook Air Apple, are included in 
the Hardware division. As mentioned beforehand, StealthStation S8, both Software and 
Hardware, are provided by the Hospital Clínic of Barcelona, thus reducing all the potential cost of 
it.  Moreover, the cost of the computer is estimated to be of 1.300€.  
The total cost of the study computed in collaboration with the Hospital Clínic and the University of 
Barcelona is of 8.100€, and the budget is shown in Table 12. 
The cost divided per specific activity is graphically represented in Figure 27, and it can be seen 
that the higher percentage is for the developmental stage of the project, followed by the writing 
stage and the private computer. Moreover, Figure 28 displays the cost divided per section, human 
resources, software and hardware. Most of the cost is clearly visible that it is aimed at human 
resources, as both the software and part of the hardware has been provided by the collaborating 
entities of the study.  
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0 €  
(Provided by the Hospital Clínic)
MRI Scans
0 €  
(Provided by the Hospital Clínic)
Human Resources
Educational Stage 1000 €
Developmental Stage 3000 €
Writing Stage 2800 €
Total Cost Student 6800 €
Software
StealthStation S8 Medtronic
0 €  
(Provided by the Hospital Clínic)
MATLAB University of Barcelona license
Hardware
StealthStation S8 Medtronic
0 €  
(Provided by the Hospital Clínic)







Private Computer Developmental Stage
Educational Stage Writing Stage





Figure 28. Cost divided per section: Human 
Resources, Software and Hardware
Table 12. Total budget, specified by activity, of the project
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10. PROJECT IMPLEMENTATION SCHEDULE 
10.1. GANTT DIAGRAM 
The methodology followed the whole course of the project to obtain the results has been detailed 
in a GANTT diagram shown in Figure 29. 
The study has followed a fairly linear development, where all tasks have been done sequentially. 
Nonetheless, the stage of writing the work began from the beginning and has been alternating 
with all other tasks.  
Firstly, in the educational stage, a literature review of three months was accomplished in order to 
obtain sufficient knowledge to understand brain anatomy and physiology as well as PD. On 
account of this literature search, the author was able to understand the surgical procedure and 
different studies were analysed where a study of the error in STN-DBS interventions was 
performed. Subsequently, different DBS software was studied amidst the month of November as 
well as the obtaining of the images and their anonymization during December and January.  
Later on, the developmental stage was initiated, with the co-registration and the acquisition of 
coordinates which were completed from mid-January to the first week of April to later compute the 
accuracy assessment in the course of April. While the necessary calculations and statistics were 
being performed, the author returned to intersperse them with the writing process. 
Finally, once the relationship with the symptoms has been accomplished throughout the first 
weeks of May, the work has focused on finishing the report, the writing stage, with a delivery date 
of June 14 and, once delivered, the oral presentation was prepared knowing that it will be 
presented on June 21. 
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11. CONCLUSIONS 
To conclude, this project had the objective of validating the current technique of DBS electrode 
implantation accomplished in the Hospital Clínic of Barcelona by studying the accuracy of the 
placement using CT and MRI imaging and two different software: StealthStation S8 from 
Medtronic and MATLAB in patients with PD which electrodes stimulate the STN, as well as 
establishing a possible relationship between its symptomatology and provide objective arguments 
of a fully anaesthetised patient intervention. 
Taking into account the whole population of the study, which has been 74 patients from 2015 to 
2020, the absolute average accuracy in the right hemisphere has resulted to be 1.923 mm ± 
1.107 whilst on the left hemisphere 2.364 mm ± 1.065. Consequently, in Leksell stereotactic 
system reviews have found out that the TE vary mostly from 3.00 mm to 1.33, whilst other 
systems such as the Neuromate Robot and i-MRI-guided system present a TE which is lower 
than 1 mm. In the case of the Hospital Clínic, the results are indeed consistent and statistically 
significant, nonetheless, other procedures could be adopted to perform the intervention to try to 
reduce TE as much as possible, such as a robotic arm. 
On the other hand, it has been found that when an electrode has deviated from the expected 
target, it is explanted and relocated, or even the entire DBS system is replaced. Therefore, it has 
also been verified that there is a clinic related to the proper functioning of the system and that this 
is directly related to the position of the electrodes and, therefore, also to the accuracy. 
Nevertheless, it should be recalled that this intervention provides very favourable results for 
patients, with a considerable reduction in their motor symptoms if the type III UPDRS scale is 
taken into consideration. Hence, the objective involving the intervention’s validation has been 
correctly accomplished.  
Additionally, the image-guided and image-verified technique has been verified for having good 
accuracy while having the patient completely anaesthetised during the whole procedure, fulfilling 
the second and the third objective of the study. Thanks to this methodology, moving away from 
the MER-guided surgery, the patient can be asleep and would not have to withdraw his 
medication, thence relieving the preoperative anxiety he could be suffering from.  
For the time being, in the majority of hospitals in Catalonia, the procedure is still being realised 
using the MER technique, resulting in a more extensive and longer surgery. Therefore, in the 
case of Parkinson's patients with STN stimulation, STN-DBS can be performed with reliable 
accuracy and offering remarkably results to the patient. 
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With regard to the limitations that have appeared in the work, the temporary limitation must be 
emphasised, since being a final degree project there is stipulated delivery date. Conversely, a 
more complete validation was desired with the study of the error of the trajectory and the 
deviations concerning the point of entry, however, it was not possible to execute since the 
necessary data had been erased. Even so, the considerable error, which is the one regarding the 
target (STN), has been successfully computed and analysed throughout the project. 
Finally, to conclude, it is considerable to highlight the importance of technology, as well as 
biomedical engineering, in the field of neurosurgery. Communication between engineers and 
doctors or surgeons enables biomedical engineers to identify real problems during surgical 
interventions and to think of solutions to those issues. It is essential to bet on the use of 
biomedical engineers in operating rooms, as well as hospitals, to evolve and implement new 
technologies for diagnosis, treatment or even to improve surgical techniques. Medicine is 
certainly a field that is evolving more slowly than the rest, but it has the opportunity to take 
advantage of technological advances including robotics or artificial intelligence, and implement 
them on a day-to-day basis to facilitate procedures, alongside improving and making the patient’s 
stay in the hospital more comfortable. On account of this, little by little biomedical engineers will 
be introduced even more into health systems to improve and help doctors to treat patients, and 
their presence will increase in the following years to come. 
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ANNEXES 
Patient’s AC-PC Coordinates 
VIII
Patients X right (mm) Y right (mm) Z right (mm) X left (mm) Y left (mm) Z left (mm)
3 13.28 -1.1 -4.31 -12.88 0.55 -5.21
4 11.03 -2 -4.45 -10.24 -2 -5
6 12.84 -2.66 -4 -11.22 -2.66 -4
7 11.55 -1.58 -4 -10.87 -1.02 -4
8 12.8 -2.95 -4 -11.6 -2.5 -4
9 10.07 -2.4 -4 -10.14 -2.21 -4
10 12 -2 -4 -12.69 -2 -4
11 10.14 -1 -4 -10.34 -1 -4
12 11.37 -4.82 -4 -11.9 -2 -4
13 10.46 -3.3 -4 -10.46 -2.4 -4
14 10.34 -2.5 -4 -10.62 -2.27 -4
15 11.4 -1 -4 -11.14 -0.45 -4
18 9.34 -3.54 -4 -9.8 -2.28 -4
20 10.77 -0.53 -4 -10.23 -1.67 -4
21 11 -2.9 -4 -9.24 -2.55 -4
22 10.57 -2.77 -3.28 -11.11 -1.79 -2.19
23 12.16 -2.76 -4 -12.3 -0.55 -3.75
24 15.24 -3.93 1.37 -11.92 -4.39 2.13
25 11.43 -4.05 -4 -9.12 -2.5 -4
28 11.16 -2 -4 -11.58 -2.63 -4
30 11.85 -0.9 -4 -9.62 -2.21 -4
31 12 -4 -4 -10.6 -2.63 -4.43
32 11.52 -2.32 -4 -11.68 -2.69 -4
33 11.47 -1.5 -4 -9.43 -2.9 -4
35 11.26 -6.29 -4 -12.33 -4.66 -3
36 13.35 -4 -2.33 -12.02 -3.95 -2.52
37 12.38 -1.03 -4 -10.14 -2.6 -4
38 10.82 -1.93 -4 -10.92 -2 -4
39 12.5 -2.05 -4 -10.47 -3 -4
40 12 -4 -4 -11.78 -4.28 -4.12
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41 10 -1.63 -4 -9.5 -2.2 -4.2
42 10.28 -1.5 -3.63 -9.59 -2.14 -3.5
43 10 -3.52 -4.33 -9.29 -2.77 -4.28
44 10.62 -4.85 -4 -10.03 -5.12 -4.28
45 12.67 -0.18 -3.1 -9.81 -2.75 -4.12
46 12.19 -1.89 -4 -9.69 -3.7 -4
47 11.67 -0.95 -4 -11.67 -0.95 -4
48 12.93 -1.95 -4 -9.88 -3.41 -4
50 11.88 -1.65 -4 -9.32 -2 -4
51 12.8 -1.4 -4 -10.54 -2.1 -4
52 11.6 -2.31 -4 -11.58 -2.62 -4
53 12 -4 -4 -11 -3 -4
54 13.5 -4.4 -1.37 -12.9 -4.04 -1.41
55 12.9 -1.4 -3.8 -12.54 -1.21 -3.76
56 12 -4 -4 -12 -4 -4
57 9.95 -3.6 -4.22 -7.24 -5.39 -4
58 11.04 -3.68 -3.92 -12 -4 -4
59 11.83 -0.61 -4 -10.67 -2.1 -4
60 10.25 -4.24 -3.46 -12.32 -3.71 -2.51
62 12 -4 -4 -12.62 -3.96 -4
65 12 -4 -4 -12.73 -3.45 -4
66 12 -3 -4 -11.45 -3 -4
67 12.46 -3.5 -4 -10 -2.5 -4
68 11 -2.9 -3.9 -12.06 -3 -3.95
69 12 -4 -4 -11.16 -3 -4
70 11 -2.5 -4 -9.5 -3.06 -4
72 12 -4 -4 -12.25 -2 -4.11
73 10.26 -4 -3.66 -9.5 -4 -4
74 11.41 -3 -4 -8.74 -3.5 -4
75 12 -1.9 -4.17 -12.38 -1.63 -3.87
76 10 -3.6 -4 -8 -4 -4
77 10.19 -3 -4 -11 -4 -4
78 10.57 -2 -3 -10.51 -3 -4
79 12 -1 -4 -10 -1 -4
80 12.11 -3.19 -4 -12 -2 -4.3
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for i = 1:1:76
    data_def_x = target(:,i+1); %All x values
    data_def_y = target(:,i+2); %All y values
    data_def_z = target(:,i+3); %All z values
    d_right = sqrt((data_def_x-x0_r).^2+(data_def_y-
y0_r).^2+(data_def_z-z0_r).^2)
end






81 10.5 -1.8 -3.9 -10 -2 -4.14
82 12.8 0.73 -3.63 -10 0.26 -3.8
83 12 -4 -4 -12 -4 -4
84 10.7 -2 -4 -9.3 -3.5 -4
86 9.33 -2.57 -4.03 -9.58 -0.54 -3.77
87 11.73 -2.71 -3.02 -12.59 -0.89 -3.72
89 10.9 -4 -3.9 -10 -4 -4
90 9.42 -1.12 -4.17 -9.35 -1.14 -4
92 11.87 -3.16 -4.43 -10.31 -3 -4
93 10.15 -3.36 -4 -10.13 -3.18 -4
94 12 -4 -4 -10.13 -4.3 -4
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for i = 1:1:76
    data_def_x = target(:,i+4); %All x values
    data_def_y = target(:,i+5); %All y values
    data_def_z = target(:,i+6); %All z values
    d_left = sqrt((data_def_x-x0_l).^2+(data_def_y-
y0_l).^2+(data_def_z-z0_l).^2)
end
MATLAB code to accomplish the statistical analysis 
%Statistical Appraisal
clc
clear all
distance = linspace(0,76,76);
v_error = csvread("vectorerror.csv",1,0);
%Average errors
mean_right = mean(v_error(:,1));
mean_left = mean(v_error(:,2));
%Standard deviation
sd_right = std(v_error(:,1));
sd_left = std(v_error(:,2));
%Paired Student T-Test
[h,p] = ttest(v_error(:,1),v_error(:,2));
h
p
%Colour
c = "r"
%Plot representation
scatter(v_error(:,2),v_error(:,4), c);
title('Left Vector Error')
xlabel('Vector Error')
ylabel("Distance from AC-PC")
XI
